The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats

Hepatology

Volumn 16, Issue 4, 1992, Pages 1043-1048

  Lee, Fa‐Yauh ^a,b   Albillos, Agustin ^a,b   Colombato, Luis A ^a,b   Groszmann, Roberto J ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; METHOXAMINE; N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART INDEX; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; THERMODILUTION; VASCULAR RESISTANCE;

ANIMAL; ARGININE; BLOOD PRESSURE; BLOOD VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION, PORTAL; MALE; METHOXAMINE; NITRIC OXIDE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; VASCULAR RESISTANCE;

EID: 0026737603     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840160430     Document Type: Article

References (29)

1. Portal hypertension
2. Hepatic and systemic hemodynamics and the neurohumoral systems in cirrhosis
3. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats
4. Decreased pressor reactivity to angiotensin II in cirrhotic rats: evidence for a post‐receptor defect in angiotensin action
5. Pressor resistance to vasopressin in sodium depletion, potassium depletion and cirrhosis
6. Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis
7. Vascular reactivity in experimental portal hypertension
8. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism
9. Intestinal vascular sensitivity to vasopressin in portal hypertensive rats
10. Hemodynamics and hormonal alterations in hepatic cirrhosis
11. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension
12. Role of glucagon in splanchnic hyperemia of chronic portal hypertension
13. Endothelium‐derived relaxing and contracting factors
14. Role of endothelium‐derived nitric oxide in the regulation of blood pressure
15. Nitric oxide release accounts for the biological activity of endothelium‐derived relaxing factor
16. Vascular endothelial cells synthesize nitric oxide from L‐arginine
17. Modulation of vascular smooth muscle contraction by the endothelium
18. Modulation of angiotensin II–induced vasoconstriction by endothelium‐derived relaxing factor in the isolated microperfused rabbit afferent arteriole
19. ω‐nitro‐L‐arginine: a potent inhibitor of endothelium‐derived relaxing factor formation
20. Measurement of portal‐systemic shunting in the rat by using γ‐labeled microspheres
21. Vasodilatation and sodium retention in prehepatic portal hypertension
22. L‐arginine is the physiological precursor for the formation of nitric oxide in endothelium‐dependent relaxation
23. Pressor effect of endothelium‐derived relaxing factor inhibition in conscious virgin and gravid rats
24. Resource sharing in rat gestation: role of maternal cardiovascular hemodynamics
25. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension
26. Responses of femoral resistance vessels to angiotensin in vitro
27. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade
28. Nitric oxide mediates in vitro hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats
29. Biosynthesis of nitric oxide from L‐arginine: a pathway for the regulation of cell function and communication